Ahn-Gook Pharmaceutical Co., Ltd. - Company Capsule by Canadean

VIEWS: 9 PAGES: 25

More Info
									Ahn-Gook Pharmaceutical Co., Ltd.

_________________________________________________________________________________



Ahn-Gook Pharmaceutical Co., Ltd.                                  Financial Snapshot

                                                                   Operating Performance
Fast Facts
                                993-75, Daerim-Dong, Seoul, 150-   The company reported revenue of US$112.04 million
Headquarters Address
                                823,South Korea                    during the fiscal year 2011 (2011). The company's
                                                                   revenue grew at a CAGR of 12.87% during 2007–
Telephone                        + 82 2 32894200
                                                                   2011, with an annual growth of 15.20% over 2010. In
                                                                   2011, the company recorded an operating margin of
Fax                              + 82 2 8494124                    8.25%, as against 15.68% in 2010.

Website                         www.ahn-gook.com
                                                                   Revenue and Margins
Ticker Symbol, Stock Exchange   001540, KOSDAQ

Number of Employees             401

Fiscal Year End                 December

Revenue (in US$ million)        112.04

Revenue (in KRW million)        129,946.39




___________________________________________________________________________________________

Ahn-Gook Pharmaceutical Co., Ltd. - Company Capsule                                                     Page 1
Ahn-Gook Pharmaceutical Co., Ltd.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1     Company Overview .................................................................................................................................................5
    1.2     Major Products and Services ...................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 8
    2.1     Five Year Snapshot: Overview of Financial and Operational Performance Indicators ...........................................8
    2.2     Key Financial Performance Indicators ...................................................................................................................11
      2.2.1        Revenue and Operating Profit .......................................................................................................................11
      2.2.2        Asset, Liabilities and Capex ..........................................................................................................................12
      2.2.3        Net Debt vs. Gearing Ratio ............................................................................................................................13
      2.2.4        Operational Efficiency ....................................................................................................................................14
      2.2.5        Solvency ........................................................................................................................................................15
      2.2.6        Valuation ........................................................................................................................................................16
    2.3     Key Competitors ....................................................................................................................................................17
3     Key Employees ...................................................................................................................................... 18
4     Locations and Subsidiaries ........................................................................................................
								
To top